Clinical Trial Update: Memantine in Patients With Chronic Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating memantine for open-angle glaucoma (chronic glaucoma) sponsored by Allergan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Allergan | Conditions: Open-Angle Glaucoma | Phase 3 | Status: COMPLETED